Annual report pursuant to Section 13 and 15(d)


Cover - USD ($)
12 Months Ended
Dec. 31, 2023
Mar. 22, 2024
Jun. 30, 2023
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2023    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 001-36672    
Entity Registrant Name KIORA PHARMACEUTICALS, INC    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 98-0443284    
Entity Address, Address Line One 332 Encinitas Blvd.    
Entity Address, Address Line Two Suite 102    
Entity Address, City or Town Encinitas    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 92024    
City Area Code 858    
Local Phone Number 224-9600    
Title of 12(b) Security Common Stock, $0.01 par value    
Trading Symbol KPRX    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction false    
Entity Shell Company false    
Entity Public Float     $ 4,762,870
Entity Common Stock, Shares Outstanding   26,256,197  
Entity Central Index Key 0001372514    
Document Fiscal Year Focus 2023    
Document Fiscal Period Focus FY    
Amendment Flag false